Showing 11,901 - 11,920 results of 24,043 for search '(( 5 mm decrease ) OR ( 100 ((((we decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 0.89s Refine Results
  1. 11901

    Table 2_PD-1/PD-L1 inhibitors plus bevacizumab plus chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy for advanced non-small cell lung cancer: a phase 3 RCT based meta-an... by Chao Song (379006)

    Published 2025
    “…</p>Results<p>Three RCTs (IMpower150, jRCT2080224500, and ORIENT-31) comprising a total of 1529 patients were analyzed. The PIBC regimen significantly improved PFS (hazard ratio [HR]: 0.76 [0.66, 0.87], P < 0.0001), objective response rate (risk ratio [RR]: 1.36 [1.22, 1.51], P < 0.00001), and disease control rate (RR: 1.06 [1.00, 1.12], P = 0.04). …”
  2. 11902

    Image 3_PD-1/PD-L1 inhibitors plus bevacizumab plus chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy for advanced non-small cell lung cancer: a phase 3 RCT based meta-an... by Chao Song (379006)

    Published 2025
    “…</p>Results<p>Three RCTs (IMpower150, jRCT2080224500, and ORIENT-31) comprising a total of 1529 patients were analyzed. The PIBC regimen significantly improved PFS (hazard ratio [HR]: 0.76 [0.66, 0.87], P < 0.0001), objective response rate (risk ratio [RR]: 1.36 [1.22, 1.51], P < 0.00001), and disease control rate (RR: 1.06 [1.00, 1.12], P = 0.04). …”
  3. 11903

    Table 5_PD-1/PD-L1 inhibitors plus bevacizumab plus chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy for advanced non-small cell lung cancer: a phase 3 RCT based meta-an... by Chao Song (379006)

    Published 2025
    “…</p>Results<p>Three RCTs (IMpower150, jRCT2080224500, and ORIENT-31) comprising a total of 1529 patients were analyzed. The PIBC regimen significantly improved PFS (hazard ratio [HR]: 0.76 [0.66, 0.87], P < 0.0001), objective response rate (risk ratio [RR]: 1.36 [1.22, 1.51], P < 0.00001), and disease control rate (RR: 1.06 [1.00, 1.12], P = 0.04). …”
  4. 11904

    Table 6_PD-1/PD-L1 inhibitors plus bevacizumab plus chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy for advanced non-small cell lung cancer: a phase 3 RCT based meta-an... by Chao Song (379006)

    Published 2025
    “…</p>Results<p>Three RCTs (IMpower150, jRCT2080224500, and ORIENT-31) comprising a total of 1529 patients were analyzed. The PIBC regimen significantly improved PFS (hazard ratio [HR]: 0.76 [0.66, 0.87], P < 0.0001), objective response rate (risk ratio [RR]: 1.36 [1.22, 1.51], P < 0.00001), and disease control rate (RR: 1.06 [1.00, 1.12], P = 0.04). …”
  5. 11905

    Table 4_PD-1/PD-L1 inhibitors plus bevacizumab plus chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy for advanced non-small cell lung cancer: a phase 3 RCT based meta-an... by Chao Song (379006)

    Published 2025
    “…</p>Results<p>Three RCTs (IMpower150, jRCT2080224500, and ORIENT-31) comprising a total of 1529 patients were analyzed. The PIBC regimen significantly improved PFS (hazard ratio [HR]: 0.76 [0.66, 0.87], P < 0.0001), objective response rate (risk ratio [RR]: 1.36 [1.22, 1.51], P < 0.00001), and disease control rate (RR: 1.06 [1.00, 1.12], P = 0.04). …”
  6. 11906

    Image 1_PD-1/PD-L1 inhibitors plus bevacizumab plus chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy for advanced non-small cell lung cancer: a phase 3 RCT based meta-an... by Chao Song (379006)

    Published 2025
    “…</p>Results<p>Three RCTs (IMpower150, jRCT2080224500, and ORIENT-31) comprising a total of 1529 patients were analyzed. The PIBC regimen significantly improved PFS (hazard ratio [HR]: 0.76 [0.66, 0.87], P < 0.0001), objective response rate (risk ratio [RR]: 1.36 [1.22, 1.51], P < 0.00001), and disease control rate (RR: 1.06 [1.00, 1.12], P = 0.04). …”
  7. 11907

    Image 5_PD-1/PD-L1 inhibitors plus bevacizumab plus chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy for advanced non-small cell lung cancer: a phase 3 RCT based meta-an... by Chao Song (379006)

    Published 2025
    “…</p>Results<p>Three RCTs (IMpower150, jRCT2080224500, and ORIENT-31) comprising a total of 1529 patients were analyzed. The PIBC regimen significantly improved PFS (hazard ratio [HR]: 0.76 [0.66, 0.87], P < 0.0001), objective response rate (risk ratio [RR]: 1.36 [1.22, 1.51], P < 0.00001), and disease control rate (RR: 1.06 [1.00, 1.12], P = 0.04). …”
  8. 11908

    Table 1_PD-1/PD-L1 inhibitors plus bevacizumab plus chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy for advanced non-small cell lung cancer: a phase 3 RCT based meta-an... by Chao Song (379006)

    Published 2025
    “…</p>Results<p>Three RCTs (IMpower150, jRCT2080224500, and ORIENT-31) comprising a total of 1529 patients were analyzed. The PIBC regimen significantly improved PFS (hazard ratio [HR]: 0.76 [0.66, 0.87], P < 0.0001), objective response rate (risk ratio [RR]: 1.36 [1.22, 1.51], P < 0.00001), and disease control rate (RR: 1.06 [1.00, 1.12], P = 0.04). …”
  9. 11909

    Image 6_PD-1/PD-L1 inhibitors plus bevacizumab plus chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy for advanced non-small cell lung cancer: a phase 3 RCT based meta-an... by Chao Song (379006)

    Published 2025
    “…</p>Results<p>Three RCTs (IMpower150, jRCT2080224500, and ORIENT-31) comprising a total of 1529 patients were analyzed. The PIBC regimen significantly improved PFS (hazard ratio [HR]: 0.76 [0.66, 0.87], P < 0.0001), objective response rate (risk ratio [RR]: 1.36 [1.22, 1.51], P < 0.00001), and disease control rate (RR: 1.06 [1.00, 1.12], P = 0.04). …”
  10. 11910

    Expression of <i>PAX</i> genes and MRFs during G<sub>0</sub> entrance (SM), exit (GM) and differentiation (DM). (A) <i>PAX3</i> and <i>PAX7</i> expression levels were high in G<sub... by Jeeva Sellathurai (399773)

    Published 2013
    “…After 6 h in SM only 2.5% (±1.1 SEM) of the cells were MYOGENIN positive and the fraction decreased further during culture in SM with a tendency for an increase up to 2.8% (±2.0 SEM). …”
  11. 11911

    Synthesis and Decomposition of Alkyl Complexes of Molybdenum(IV) That Contain a [(Me<sub>3</sub>SiNCH<sub>2</sub>CH<sub>2</sub>)<sub>3</sub>N]<sup>3-</sup> Ligand. Direct Detection... by Richard R. Schrock (1295601)

    Published 1997
    “…Below ∼50 K the effective moments undergo a sharp decrease as a consequence of what are proposed to be a combination of spin−orbit coupling and zero field splitting effects. …”
  12. 11912
  13. 11913

    <b>Role of the Chaperone ClpB in</b><b> </b><b>Mycoplasma bovis</b><b> Virulence: Implications for </b><b>stress response, a</b><b>dhesion, </b><b>b</b><b>iofilm </b><b>d</b><b>eve... by Hui zhang (22187170)

    Published 2025
    “…<p dir="ltr">ClpB, an ATP-dependent molecular chaperone belonging to the Hsp100/Clp subfamily of AAA+ ATPases, plays a crucial role in protein disaggregation, thereby enhancing bacterial survival under stress conditions. …”
  14. 11914

    Propagation of the DMI signal into flanking regions in simulated data (sampled at generation 30, significance threshold: <i>X</i>(2)<−0.005 & <i>D’</i><0) when only homozygous geno... by Juan Li (146180)

    Published 2022
    “…To resemble the demography of the studied hybrid swordtail fish populations, the admixture proportion was set to <i>f</i> = 0.3 and the migration rate was <i>m</i> = 0.01. 200 individuals were sampled from each simulation to obtain the statistics. A. The number of significant marker pairs decreases rapidly with distance to the nearest true DMI locus. …”
  15. 11915

    DataSheet1_Saccharomyces cerevisiae surface display of endolysin LysKB317 for control of bacterial contamination in corn ethanol fermentations.PDF by Shao-Yeh Lu (9355095)

    Published 2023
    “…Yeast surface-expressed endolysin demonstrated an 83.8% decrease in bacterial cell counts compared to a 9.5% decrease in control yeast. …”
  16. 11916

    Minimal photobleaching of mbYFPQS occurs with repeated photo-stimulation. by Spencer D. Watts (327115)

    Published 2013
    “…<p>A. A cultured midbrain neuron expressing mbYFPQS was imaged with an exposure of 100 ms every 5 s for 35 min with less than 6% decrease in baseline fluorescence. …”
  17. 11917

    Epidemiological characterization and prognostic factors in patients with confirmed cerebral cryptococcosis in central Taiwan by Chang-Hua Chen (5668046)

    Published 2018
    “…</p>Conclusions<p>We strongly recommend early administration of an antifungal agent to each suspected cryptococcal meningitis patient to decrease both the delay by doctors in administering therapy and the mortality risk. …”
  18. 11918

    Suppression of [Ca<sup>2+</sup>]<sub>i</sub> by inhibiting L-type VDCCs is necessary for bitter tastant-induced bronchodilation of Mch precontracted mouse airways. by Cheng-Hai Zhang (385288)

    Published 2013
    “…Left panel: a typical time course; ΔF/F<sub>0</sub> for each curve is scaled to have a value of 100 at the peak before chloro is added. …”
  19. 11919

    Higher Recovery and Better Energy Dissipation at Faster Strain Rates in Carbon Nanotube Bundles: An <i>in-Situ</i> Study by Siddhartha Pathak (1895554)

    Published 2012
    “…In addition, we report a 6-fold increase in elastic modulus and gradual decrease in recoverability (down to 50%) when VACNT bundles are unloaded from postdensification stage as compared with predensification. …”
  20. 11920

    Higher Recovery and Better Energy Dissipation at Faster Strain Rates in Carbon Nanotube Bundles: An <i>in-Situ</i> Study by Siddhartha Pathak (1895554)

    Published 2012
    “…In addition, we report a 6-fold increase in elastic modulus and gradual decrease in recoverability (down to 50%) when VACNT bundles are unloaded from postdensification stage as compared with predensification. …”